← European Medicine Shortage Tracker · all medicines
Nonakog beta-pegol currently has availability issues reported in 1 European register: Sweden.
Shortage ATC — · also listed as: nonakog beta-pegol · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Nonakog beta-pegol, covering 3 affected product presentations. The longest-running open report was filed in Sweden on 2026-02-13 and has now been open for about 6 months. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇸🇪 Sweden | Shortage Refixia 1000 IE Pulver och vätska till injektionsvätska, lösning + 2 more productsRefixia 2000 IE Pulver och vätska till injektionsvätska, lösning Refixia 3000 IE Pulver och vätska till injektionsvätska, lösning | 2026-02-13 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Nonakog beta-pegol in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Refixia 2000 IE Pulver och vätska till injektionsvätska, lösning | Expected shortage | 2026-08-20 | 2026-12-31 | |
| 🇸🇪 SE | Refixia 1000 IE Pulver och vätska till injektionsvätska, lösning | Shortage | 2026-06-30 | 2026-12-31 | |
| 🇸🇪 SE | Refixia 3000 IE Pulver och vätska till injektionsvätska, lösning | Shortage | 2026-02-13 | 2026-12-31 |
Yes. As of 7 August 2026, availability issues are reported in: Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Nonakog beta-pegol: Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Nonakog beta-pegol — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/nonakog-beta-pegol/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Nonakog beta-pegol availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/nonakog-beta-pegol/">Nonakog beta-pegol shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>